Abstract
Based on the mixing tank and tube models for drug absorption, the apparent absorption rate constant is shown to be related to the fraction of dose absorbed as a function of the volume/flow ratio of GI fluids. This analysis applies to drugs that are absorbed according to first-order kinetics, without limitation by dissolution rate, lumenal decomposition, or first-pass metabolism. Analysis of pharmacokinetic data of drugs that fit these criteria and are absorbed to varying extents enabled the estimation of the volume/flow ratio of GI fluids in humans; it was found to be 1.6 ± 0.3 (SE) hr using a mixing tank model and 0.32 ± 0.05 hr using a tube model. These findings are discussed with respect to volume and flow parameters used in the design of various types of drug absorption studies.
Similar content being viewed by others
REFERENCES
H. Stricker. Drugs Made Ger. 13:35–42 (1970).
H. Stricker. Drugs Made Ger. 14:93–97 (1971).
J. B. Dressman, D. Fleisher, and G. L. Amidon. J. Pharm. Sci. 73:1274–1279 (1984).
J. B. Dressman, G. L. Amidon, and D. Fleisher. J. Pharm. Sci. 74:588–589 (1985).
J. B. Dressman and D. Fleisher. J. Pharm. Sci. 75:109–116 (1986).
B. C. Goodacre and R. J. Murray. J. Clin. Hosp. Pharm. 6:117–133 (1981).
N. F. H. Ho, H. P. Merkle, and W. I. Higuchi. Drug Dev. Ind. Pharm. 9:1111–1184 (1983).
P. Macheras and M. Symillides. Biopharm. Drug Dispos. 10:43–53 (1989).
D. Winne. J. Pharmacokin. Biopharm. 5:53–94 (1977).
R. L. Elliot, G. L. Amidon, and E. N. Lightfoot. J. Theor. Biol. 87:757–771 (1980).
G. L. Amidon, J. Kou, R. L. Elliot, and E. N. Lightfoot. J. Pharm. Sci. 69:1369–1373 (1980).
G. L. Amidon, P. J. Sinko, and D. Fleisher. Pharm. Res. 5:651–654 (1988).
P. J. Sinko, G. D. Leesman, and G. L. Amidon. Submitted for publication.
R. L. Dillard, H. Eastman, and J. S. Fordtran. Gastroenterology 49:58–66 (1965).
W. G. Karr and W. O. Abbott. J.Clin. Invest. 14:893–900 (1935).
P. Kerlin, A. Zinsmeister, and S. Phillips. Gastroenterology 82:701–706 (1982).
E. A. Mayer, J. B. Thompson, D. Jehn, T. Reedy, J. Elashoff, and J. H. Meyer. Gastroenterology 83:184–192 (1982).
A. M. Stephen, A. C. Haddad, and S. F. Phillips. Gastroenterology 85:589–595 (1983).
R. E. Notari, J. L. DeYoung, and R. Reuning. J. Pharm. Sci. 61:135–138 (1972).
P. Miranda and R. M. Blum. J. Antimicrob. Chemother. 12(Suppl. B):29–37 (1983).
M. Gibaldi and D. Perrier. Pharmacokinetics, Marcel Dekker, New York, 1975, p. 37.
E. R. Garrett, J. R. Green, and M. Bialer. Biopharm. Drug Disp. 3:129–164 (1982).
V. Ascalone, M. Cisternino, N. Sicolo, and E. Palo. Arzneim. Forsch. 34:96–98 (1984).
A. A. Holazo, W. A. Colburn, J. H. Gustafson, R. L. Young, and M. Parsonnet. J. Pharm. Sci. 73:1108–1113 (1984).
K. J. Kripalani, D. N. McKinstry, S. M. Singhvi, D. A. Willard, R. A. Vukovich, and B. H. Migdalof. Clin. Pharmacol. Ther. 27:636–641 (1980).
J. Zhu and T. Koizumi. J. Pharmacobio-Dyn. 10:370–376 (1987).
L. Zecca, L. Reina, F. Scaglione, P. Ferrario, R. Pirola, G. Ceccarelli, M. Ciampini, and F. Fraschini. Arzneim. Forsch. 35:1870–1872 (1985).
J. Kampmann and L. Skovsted. Acta Pharmacol. Toxicol. 35:361–369 (1974).
S. L. Johnson, M. Mayersohn, and K. A. Conrad. Clin. Pharmacol. Ther. 38:331–335 (1985).
P. A. Koch, C. A. Schultz, R. J. Wills, S. L. Hallquist, and P. G. Welling. J. Pharm. Sci. 67:1533–1535 (1978).
T. M. Ludden, D. A. Boyle, D. Gieseker, G. T. Kennedy, M. H. Crawford, L. K. Ludden, and W. A. Clementi. J. Pharm. Sci. 77:779–783 (1988).
S. S. Walkenstein, J. K. Dubb, W. C. Randolph, W. J. Westlake, R. M. Stote, and A. P. Intoccia. Gastroenterology 74:360–365 (1978).
P. G. Welling, H. Huang, P. F. Hewitt, and L. Lyons. J. Pharm. Sci. 67:764–766 (1978).
P. K. Narang, R. Wilder, D. C. Chatterji, R. L. Yeager, and J. F. Garelli. Biopharm. Drug Disp. 4:233–248 (1983).
P. G. Welling, L. L. Lyons, W. A. Craig, and G. Trochta. Clin. Pharmacol. Ther. 17:475–480 (1975).
P. G. Welling, L. L. Lyons, F. L. S. Tse, and W. A. Craig. Clin. Pharmacol. Ther. 19:559–565 (1976).
P. G. Welling, H. Huang, P. A. Koch, W. A. Craig, and P. O. Masden. J. Pharm. Sci. 66:549–552 (1977).
P. G. Welling, H. Huang, P. F. Hewitt, and L. L. Lyons. J. Pharm. Sci. 67:764–766 (1978).
P. G. Welling and R. H. Barbhaiya. J. Pharm. Sci. 71:32–35 (1982).
P. G. Welling, P. A. Koch, C. C. Lau, and W. A. Craig. Antimicrob. Agents Chemother. 11:462–469 (1977).
F. L. S. Tse, J. M. Jaffe, K. A. Mart, and H. Z. Schwartz. J. Pharm. Pharmacol. 36:56–58 (1984).
J. R. Malagelada, J. S. Robertson, M. L. Brown, M. Remington, J. A. Duenes, G. M. Thomforde, and P. W. Carryer. Gastroenterology 87:1255–1263 (1984).
R. Oberle. In The Influence of the Inter-digestive Migrating Myoelectric Complex on the Gastric Emptying of Liquids and Oral Absorption of Cimetidine, Ph.D. thesis, University of Michigan, Ann Arbor, 1988.
J.G. Moore, P. E. Christian, and R. E. Coleman. Digest. Dis. Sci. 26:16–22 (1981).
W. Brener, T. R. Hendrix, and P. R. McHugh. Gastroenterology 85:76–82 (1983).
S. S. Davis, R. Khosla, C. G. Wilson, and N. Washington. Int. J. Pharm. 35:253–258 (1987).
A.E. Merfeld, A. R. Mlodozeniec, M. A. Cortese, J. B. Rhodes, J. B. Dressman, and G. L. Amidon. J. Pharm. Pharmacol. 38:815–822 (1986).
N. Vidon, D. Evard, J. Godbillon, M. Rougier, M. Duval, J. P. Schoeller, J. J. Bernier, and J. Hirtz. Br. J. Clin. Pharmacol. 19:107S–112S (1985).
G. L. Amidon, A. E. Merfeld, and J. B. Dressman. J. Pharm. Pharmacol. 38:363–368 (1986).
P. J. Sinko and G. L. Amidon. Pharm. Res. 5:645–650 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Macheras, P., Reppas, C. & Dressman, J.B. Estimate of Volume/Flow Ratio of Gastrointestinal (GI) Fluids in Humans Using Pharmacokinetic Data. Pharm Res 7, 518–522 (1990). https://doi.org/10.1023/A:1015825018361
Issue Date:
DOI: https://doi.org/10.1023/A:1015825018361